Literature DB >> 27475958

Chronic oral mucositis after radiotherapy to the head and neck: a new insight.

Sharon Elad1,2, Yehuda Zadik3,4.   

Abstract

PURPOSE: Oral mucositis is a major complication of anticancer therapy yet the literature focuses on immediate (acute) mucosal changes and hardly describes the chronic form. We aim to report the clinical manifestations of chronic mucositis.
METHODS: A retrospective chart review of oral mucositis referrals was performed. Inclusion/exclusion criteria defined the patients that were considered to have chronic mucositis.
RESULTS: Four female patients treated for tongue/lower lip squamous cell carcinoma were included. Extensive painful oral mucositis lesions developed in all patients during the course of radiotherapy, with ulcers remaining for 5-24 months after completion of therapy. We describe two presentations, namely the persistent form (long-lasting ulcers continuing from acute ulcers) and the recurrent form (new discrete ulcers appearing on atrophic mucosa following the completion of radiotherapy).
CONCLUSIONS: The long-term oral complications of radiotherapy to the head and neck may include chronic atrophic, erythematous, and/or ulcerated lesions. A diagnosis of chronic oral mucositis should be considered when the lesions are observed at least 3 months after radiotherapy, and other possible etiologies have been excluded. The influence of age and comorbidities (primarily diabetes mellitus) on chronic mucositis, the significance to patient's quality of life, and the management of chronic mucositis are important subjects for future research.

Entities:  

Keywords:  Chronic; Oral cancer; Oral medicine; Oral mucositis; Oral oncology; Radiation therapy; Radiotherapy

Mesh:

Year:  2016        PMID: 27475958     DOI: 10.1007/s00520-016-3337-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  22 in total

1.  Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer.

Authors:  Guido B van den Broek; Alfons J M Balm; Michiel W M van den Brekel; Michael Hauptmann; Jan H Schornagel; Coen R N Rasch
Journal:  Radiother Oncol       Date:  2006-10-19       Impact factor: 6.280

2.  Relation of mucous membrane alterations to oral intake during the first year after treatment for head and neck cancer.

Authors:  Barbara Roa Pauloski; Alfred W Rademaker; Jerilyn A Logemann; Donna Lundy; Michelle Bernstein; Carrie McBreen; Daphne Santa; Angela Campanelli; Lisa Kelchner; Bernice Klaben; Muveddet Discekici-Harris
Journal:  Head Neck       Date:  2010-08-24       Impact factor: 3.147

Review 3.  Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients.

Authors:  Deborah P Saunders; Joel B Epstein; Sharon Elad; Justin Allemano; Paolo Bossi; Marianne D van de Wetering; Nikhil G Rao; Carin Potting; Karis K Cheng; Annette Freidank; Michael T Brennan; Joanne Bowen; Kristopher Dennis; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2013-07-06       Impact factor: 3.603

Review 4.  Oral mucositis.

Authors:  Judith E Raber-Durlacher; Sharon Elad; Andrei Barasch
Journal:  Oral Oncol       Date:  2010-04-18       Impact factor: 5.337

5.  Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors.

Authors:  Stefan Wuketich; Stefan A Hienz; Christine Marosi
Journal:  Support Care Cancer       Date:  2011-02-18       Impact factor: 3.603

Review 6.  Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients.

Authors:  Cesar Migliorati; Ian Hewson; Rajesh V Lalla; Heliton Spindola Antunes; Cherry L Estilo; Brian Hodgson; Nilza Nelly Fontana Lopes; Mark M Schubert; Joanne Bowen; Sharon Elad
Journal:  Support Care Cancer       Date:  2012-09-22       Impact factor: 3.603

7.  Incidence of oral mucositis, its treatment and pain management in patients receiving cancer treatment at Radiation Oncology Departments in Spanish hospitals (MUCODOL Study).

Authors:  Ana Mañas; Amalia Palacios; Jorge Contreras; Isabel Sánchez-Magro; Pilar Blanco; Cristina Fernández-Pérez
Journal:  Clin Transl Oncol       Date:  2009-10       Impact factor: 3.405

Review 8.  The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature.

Authors:  Joel B Epstein; Andrew H F Tsang; Dawn Warkentin; Jonathan A Ship
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2002-07

9.  Altered glucose metabolism during chemoradiation for head and neck cancer.

Authors:  Nam P Nguyen; Paul Vos; Vincent Vinh-Hung; Thomas L Borok; Suresh Dutta; Ulf Karlsson; Howard Lee; Tomas Martinez; Beng-Hoey Jo; Ly M Nguyen; Nga Nguyen; Sabah Sallah
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

Review 10.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Rajesh V Lalla; Joanne Bowen; Andrei Barasch; Linda Elting; Joel Epstein; Dorothy M Keefe; Deborah B McGuire; Cesar Migliorati; Ourania Nicolatou-Galitis; Douglas E Peterson; Judith E Raber-Durlacher; Stephen T Sonis; Sharon Elad
Journal:  Cancer       Date:  2014-02-25       Impact factor: 6.860

View more
  9 in total

1.  Treatment of mucositis with combined 660- and 808-nm-wavelength low-level laser therapy reduced mucositis grade, pain, and use of analgesics: a parallel, single-blind, two-arm controlled study.

Authors:  Raquel Gusmão Soares; Lucyana Conceição Farias; Agna Soares da Silva Menezes; Carla Silvana de Oliveira E Silva; Angeliny Tamiarana Lima Tabosa; Pablo Vinicyus Ferreira Chagas; Laís Santiago; Sérgio Henrique Sousa Santos; Alfredo Maurício Batista de Paula; André Luiz Sena Guimarães
Journal:  Lasers Med Sci       Date:  2018-06-15       Impact factor: 3.161

2.  Effectiveness of an Interdisciplinary Medical Hospital Admission Center: The Role of the Dental Section in the Interdisciplinary System for Perioperative Management of Patients Awaiting Surgery.

Authors:  Akifumi Enomoto; Eri Morikage; Takeshi Shimoide; Kazuhide Matsunaga; Suguru Hamada
Journal:  J Med Syst       Date:  2017-04-25       Impact factor: 4.460

3.  Management of radiation-induced mucosal necrosis with photobiomodulation therapy.

Authors:  Caroline de Bataille; Vincent Sibaud; Angélique Prioul; Anne Laprie; Emmanuelle Vigarios
Journal:  Support Care Cancer       Date:  2017-10-09       Impact factor: 3.603

4.  Effect of Tempol on the prevention of irradiation-induced mucositis in miniature pigs.

Authors:  L Hu; Y Wang; A P Cotrim; Z Zhu; R Gao; C Zheng; C M Goldsmith; L Jin; C Zhang; J B Mitchell; B J Baum; S Wang
Journal:  Oral Dis       Date:  2017-04-27       Impact factor: 3.511

5.  Oral complications at 6 months after radiation therapy for head and neck cancer.

Authors:  R V Lalla; N Treister; T Sollecito; B Schmidt; L L Patton; K Mohammadi; J S Hodges; M T Brennan
Journal:  Oral Dis       Date:  2017-08-03       Impact factor: 3.511

6.  Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022.

Authors:  Jolien Robijns; Raj G Nair; Joy Lodewijckx; Praveen Arany; Andrei Barasch; Jan M Bjordal; Paolo Bossi; Anne Chilles; Patricia M Corby; Joel B Epstein; Sharon Elad; Reza Fekrazad; Eduardo Rodrigues Fregnani; Marie-Thérèse Genot; Ana M C Ibarra; Michael R Hamblin; Vladimir Heiskanen; Ken Hu; Jean Klastersky; Rajesh Lalla; Sofia Latifian; Arun Maiya; Jeroen Mebis; Cesar A Migliorati; Dan M J Milstein; Barbara Murphy; Judith E Raber-Durlacher; Hendrik J Roseboom; Stephen Sonis; Nathaniel Treister; Yehuda Zadik; René-Jean Bensadoun
Journal:  Front Oncol       Date:  2022-08-30       Impact factor: 5.738

7.  Gold nanomaterials for oral cancer diagnosis and therapy: Advances, challenges, and prospects.

Authors:  Qing Zhang; Dan Hou; Xueying Wen; Mengyu Xin; Ziling Li; Lihong Wu; Janak L Pathak
Journal:  Mater Today Bio       Date:  2022-06-22

8.  Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma.

Authors:  Mette Marcussen; Mads Sønderkær; Julie Støve Bødker; Maria Andersen; Søren Nielsen; Charles Vesteghem; Ilse Christiansen; Olav Jonas Bergmann; Martin Bøgsted; Karen Dybkær; Mogens Vyberg; Hans Erik Johnsen
Journal:  PLoS One       Date:  2018-01-16       Impact factor: 3.240

9.  MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Authors:  Sharon Elad; Karis Kin Fong Cheng; Rajesh V Lalla; Noam Yarom; Catherine Hong; Richard M Logan; Joanne Bowen; Rachel Gibson; Deborah P Saunders; Yehuda Zadik; Anura Ariyawardana; Maria Elvira Correa; Vinisha Ranna; Paolo Bossi
Journal:  Cancer       Date:  2020-07-28       Impact factor: 6.860

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.